Elizabeth H. Federici, MD - Penn State Cancer Institute
Researcher Profile
Elizabeth H. Federici, MD
Assistant Professor, Department of Medicine
Division of Hematology and Oncology
Division of Blood and Vascular Disorders
Division of Hematology and Oncology
Division of Blood and Vascular Disorders
Research Interests
Dr. Elizabeth Federici's clinical research focuses on outcomes for patients with hematologic diseases including hemophilia and thrombosis. She is researching treatments for patients with hemophilia undergoing invasive procedures. In addition, she aims to clarify the effects of hereditary and acquired factors in the development of thrombosis.
The overall goal of her research is to improve health and quality of life for people with hematologic diseases.
- Thrombosis
- factor V Leiden
- Drug Therapy
- Breast Neoplasms
- Exercise
- Fibrosis
- Hemoglobins
- Hemophilia A
- Systemic Scleroderma
- Factor V
- Prothrombin
- Hematologic Diseases
Recent Publications
2024
for the Venous thromboEmbolism Network US (VENUS) VTE Treatment and Anticoagulation Management Group 2024, 'Primary Care Clinicians’ Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment', Journal of Clinical Medicine, vol. 13, no. 1, 96. https://doi.org/10.3390/jcm13010096
2022
Sturgeon, KM, Smith, AM, Federici, EH, Kodali, N, Kessler, R, Wyluda, E, Cream, LV, Ky, B & Schmitz, KH 2022, 'Feasibility of a tailored home-based exercise intervention during neoadjuvant chemotherapy in breast cancer patients', BMC Sports Science, Medicine and Rehabilitation, vol. 14, no. 1, 31. https://doi.org/10.1186/s13102-022-00420-6
2021
Noverati, N, Federici, E & Riley, TR 2021, 'Post-transfusion hemoglobin response in patients with cirrhosis: Can we expect a 1 g/dL rise per unit transfused?', Transfusion, vol. 61, no. 3, pp. 708-712. https://doi.org/10.1111/trf.16238